This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,883.24 firm-fixed-price delivery order is for the supply of 4565878585 - Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a period of performance through September 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between Amerisourcebergen and the DLA Troop Support Medical for a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs and facilities worldwide.
Generated 12/19/24, 9:26 AM